Correction to: Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists’ and Urologists’ Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European Countries

Laura Panattoni (), Mairead Kearney, Natalie Land, Thomas Flottemesch, Patrick Sullivan, Melissa Kirker, Murtuza Bharmal and Brett Hauber
Additional contact information
Laura Panattoni: PRECISIONheor
Mairead Kearney: Merck Healthcare KGaA
Natalie Land: PRECISIONheor
Thomas Flottemesch: PRECISIONheor
Patrick Sullivan: PRECISIONheor
Melissa Kirker: Pfizer
Murtuza Bharmal: EMD Serono, Research & Development Institute, Inc.
Brett Hauber: Pfizer

PharmacoEconomics, 2024, vol. 42, issue 8, No 8, 911 pages

Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-024-01391-x Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:42:y:2024:i:8:d:10.1007_s40273-024-01391-x

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-024-01391-x

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().